“showed a trend”

GRP transplanted animals showed a trend towards an increase in fore-limb disease onset (media: 151.0 ± 12.0 days; dead cells: 149.3 ± 13.2; GRPs: 162.6 ± 11.9: p > 0.05; Fig. 3c ); however, this change was not significant.

The Therapy ANOVA showed a trend towards a Block × Word list interaction driven by greater improvements for trained words ( P = 0.050).

Comparison between late trials in the D 2 −1 session and the early D 2 trials showed a trend toward increasing BF responses (Fig. 6c1 , significant at p < 0.05 level; Fig. 6c2 , paired t -test, p = 0.065, N = 6).

Furthermore, triple-class refractory patients showed a trend toward inferior PFS (HR: 3.76, p = 0.05) and significantly worse OS (HR: 20.46, p = 0.002) compared to non-refractory patients.

In the between-group comparisons at each time point, the experimental group showed a trend toward lower PSQI scores than the control group at the end of the intervention (p = 0.05) and had significantly lower scores at the follow-up assessment (p = 0.01) ( Figure 4 and Supplement 4 ).

No significant difference in mortality was observed across RACHS-1 categories, although patients in high-risk categories (RACHS ≥4) showed a trend toward increased mortality (72% vs . 59%, p>0.05).

GSH levels showed a trend of gradual increase, peaked in the DCP30 group ( p < 0.05), and decreased in the DCP40 and DCP50 groups ( p > 0.05).

At 18 WPV, both CD4 + ( Figure 1 A) and CD8 + ( Figure 1 B) T cells showed a trend increase ( p > 0.05) in the frequency of IFN-γ mRNA positive cells in both MLV and Combo vaccinated groups compared to control animals.

Patients' education level showed a trend towards being a determinant factor associated with lack of adherence (p = 0.05).

Notably, the beta diversity showed a trend toward statistical significance ( p = 0.05).

showed a trend toward a lower infection rate in the Ta cup group than in the Ti cup group (2.9% vs. 5%, P > 0.05).

FOXP3 + expression showed a trend toward a significant association with more favorable OS but not PFS (OS: p = 0.05, PFS: p = 0.07) (Fig. 5 , Table 5 ) using univariate analysis .

Effects of RP-GABA on growth-related measures under different THI conditions As shown in Supplementary Figure S2 , compared with the control group, RP-GABA supplementation showed a trend toward increased body weight under THI 45, THI 63, and THI 28; however, the differences between groups within each THI condition were not significant ( p > 0.05).

However, mitral valve repair showed a trend toward higher 10-year survival compared to valve replacement in both groups (87.5% vs. 76.8%; p = 0.05 and 65.9% vs. 37.5%; p = 0.01) ( Fig. 8 ).

The sibutramine group showed a trend toward a greater reduction in body fat percentage than the placebo group (p = 0.05).

The retention of PC in both single PC and microcapsules showed a trend of increasing and then decreasing with increasing concentration of sodium bisulfite solution in the range of 0.1–0.5 mg/mL ( Figure 7 D) ( p < 0.05).

From 1990 to 2019, in the gender group, only the rate and incidence of DALYs in the whole population showed a trend change with years ( p < 0.05), and the disease burden of males showed a trend change with years ( p < 0.05), while the disease burden of females did not ( p > 0.05) (Table 3 ).

The puppies in the treatment group showed a trend of reduced fat gain compared with those in the control group, and with a marginally significant difference at 6 months ( P = 0·05).

A comparison of 5 μ g/mL imatinib with 10 μ g/mL albendazole also showed a trend toward higher efficacy for imatinib, with complete protoscoleces death occurring on Days 30 and 33, respectively ( p > 0.05).

For instance, when exposed to a combination of MAP and S-200, NodB genes in CANT-HYD showed a trend similar to that of nahAa and nahAb (naphthalene 1,2-dioxygenase) predicted by PICRUSt2, with a slight decrease in abundance compared to the oil-only group (p < 0.05, one-way ANOVA; p < 0.05, t-test).

The PFS of patients presenting with pancreatic metastases on sunitinib showed a trend toward being significantly higher than for those without pancreatic metastases (HR, 0.52; 95% CI, 0.27–1.01; P = 0.05).

In HA-stimulated cells, several pathways potentially related to ERK signaling, including the calcium signaling pathway and glycerol phospholipid metabolism, showed a trend toward enrichment (nominal P -values <0.05), although they did not pass the predefined FDR threshold ( q -value <0.25) ( Supplementary Table S4 ).

The SDMT showed a trend toward significance ( p = 0.05).

In addition, in UC patients, Pseudomonas , Staphylococcus , and Dialister showed a trend of relative abundance changes (p<0.05, BH adjusted-p >0.05) when analyzed for PTPN2 genotypes ( S2 Table ) , while Lactobacillus showed a trend of relative abundance changes (p<0.05, BH adjusted-p >0.05) when analyzed for PTPN22 genotype ( S2 Table ) .

The verification results of ABHD 8, DHPS, ISOC2 and MRPL34 were consistent at the transcriptome level and qRT-PCR At the transcriptional level, 6 diagnostic genes were significantly different between normal and BC groups, The expression levels of ABHD8, DHPS, ISOC2, MRPL34 were significantly upregulated in the tumor group compared to the normal group, ESRRA and OGFR also showed a trend of high expression in the tumor group ( p < 0.05) (Fig. 8 A).